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Until recently, epithelial cells have been a largely ignored
component of host responses to microbes. However, this has
been largely overturned over the last decade as an ever
increasing number of studies have highlighted the key role
that these cells play in many of our interactions with our
microbiota and pathogens. Interactions of these cells with
Candida albicans have been shown to be critical not just in
host responses, but also in fungal cell responses, regulating
fungal morphology and gene expression proﬁle. In this
review, we will explore the interactions between C. albicans
and epithelial cells, and discuss how these interactions affect
our relationship with this fungus.
Introduction
With the increasing numbers of patients with compromised
immune responses, the last half century has seen a dramatic rise
in the incidence of fungal infections. This has come about due to
the HIV pandemic, improvement and refinement of cancer ther-
apies and transplants, as well as general improvements in life
expectancy for the population as a whole. Further, the increasing
use of long-term, in-dwelling medical devices that bypass innate
biological barriers has contributed to this increase, as they serve
as platforms for biofilm formation. As further advances are made
to increase life expectancy of immunocompromised individuals
(e.g. ever improving therapies for HIVC individuals) this trend
of increasing infection is likely to continue, ensuring that fungal
infections become a priority for global health. The most common
of the human pathogenic fungi are the Candida species – in par-
ticular Candida albicans. These fungi, although a common part
of the mycobiota at mucosal surfaces of around 50% of the
healthy population,1 are a significant cause of severe morbidity in
millions of individuals worldwide, causing candidiasis of oral,
gastrointestinal and vaginal surfaces. Further, although there is
currently a lack of good epidemiological data, Candida and other
pathogenic fungal species (Aspergillus, Cryptococcus and Pneumo-
cystis) account for as many deaths each year as tuberculosis or
malaria.2,3 Even non-lethal infections can carry significant mor-
bidity. Vulvovaginal candidiasis (VVC) affects »75% of women
at least once during their fertile years.4,5 This amounts to
»30 million infections each year, with a further 5–10% going on
to develop either recurrent or chronic candidiasis (RVVC or
CVVC).6,7 Furthermore, Candida infections are also common
oral infections, particularly in HIVC (50%) and AIDS (90%)
patients.8-10 Although Candida infections are mostly superficial,
affecting the mucosal surface at the site of infection, their invasive
nature can lead to much more serious systemic infections with a
high degree of mortality. Indeed, studies have indicated that
mucosal colonisation by Candida is a significant risk factor for
subsequent systemic infections in patients.11,12 Given the immu-
nocompromised state of many hospital patients, this has led to
Candida infections being the 3rd or 4th most common nosoco-
mial bloodstream infection.13,14
Given this ever-increasing prevalence of Candida infections, it
is therefore important to understand the events that occur during
host-Candida interaction. While much work has been done to
explore these interactions at the level of host immune cells during
systemic immunity, it is only recently that efforts have turned to
examining the events and mechanisms involved in mucosal-Can-
dida interactions – in particular the interactions between the fun-
gus and host epithelial cells. The consensus view has been that the
sole role of epithelial cells was to act as a point of attachment for
colonisation and subsequent invasion, and as a food source for the
invading fungi, with a function purely as a static barrier, rather
than as dynamically active sensors. In the light of recent studies,
however, this view has substantially changed,15-17 and epithelial
cells are now seen as playing a more active role in commensal/
pathogen discrimination, immunity and damage repair. Here, we
will review the events that occur when C. albicans meets epithelial
cells and explore their importance in host responses to the fungus.
Adhesion
The epithelial cells that comprise the majority of our mucosae
play a crucial role in preventing fungal invasion across these surfaces.
Their position at the outside surfaces of the body ensures that they
are generally the first host cell to come in to contact with the over-
whelming majority of fungi. Given this position, they play a critical
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role in initial fungal contact events – in both colonisation and inva-
sion. The key part of these initial contact events is the adherence of
fungal cells to host epithelial cells, a process whose outcome governs
all subsequent interactions between fungus and host. This adhesion
of fungus to epithelial cells is a complex process, involving several
different factors. Determining events is made somewhat tricky by a
degree of functional redundancy in different factors. These initial
contact events require a variety of passive forces, including attractive
(e.g., van der Waals forces, hydrophobic interactions) and repulsive
(e.g. mutual electrorepulsive forces) effects. Once these initial events
have allowed cell-cell contact, adhesion of C. albicans to epithelial
cells is thought to involve a series of interactions between epithelial
receptors and Candida adhesins, with these adhesins varying
depending on the morphological status of the fungus.18 Our current
knowledge of these adhesion events has relied largely on data
obtained from in vitro experiments and primarily pertains to yeast
interactions with epithelial cells. While this ignores the possible role
of many important hyphal adhesins, it is worth noting that given the
essentially sessile nature of hyphae, the majority of initial contact-
mediated adhesion is likely to be between epithelial cells and yeast
cells, with hyphae growing out of the yeast cells after first contacting
a surface. At this point, the hyphal-expressed adhesins become of pri-
mary importance, playing a significant role in the pathogenesis of the
fungus and affecting how the infection progresses. C. albicans also
forms pseudohyphae during growth on epithelial cells, but little is
known about the identity or role of pseudohyphal-specific genes
involved in the adhesion of this morphotype. Despite the dominant
role assumed for yeast cells in initial/early epithelial cell adhesion
events, there may be direct adhesion of the hyphal form of Candida
to epithelial cells without the involvement of yeast cells, as hyphae
grow from one epithelial cell to an adjoining epithelial cell. There
are a variety of adhesins present on fungal cells that interact with
host cell surface receptors (Table 1). The host ligands that these cells
interact with at epithelial cell surfaces include host extracellular
matrix (ECM) components (including laminin, fibronectin, colla-
gen, vitronectin etc18) and surface expressed receptors, such as integ-
rins and cadherins. Most recently, ErbB receptor family members
(particularly Her2) have also been demonstrated to interact with the
Candida adhesins Agglutinin-Like Sequence 3 (Als3p) and the Heat
Shock Protein, Ssa1p19 (Fig. 1).
Hwp1p (Hyphal Wall Protein 1) is one of the most exten-
sively studied adhesins. Expressed as a glycosylphosphatidylinosi-
tol-linked (GPI-linked) protein,20 this adhesin interacts with as
yet unidentified host proteins, resulting in covalent attachment
of Candida to host epithelial cells. N-terminal glutamines in
Hwp1p are cross-linked to host proteins via host transglutami-
nase activity.21 The importance of this adhesion event can be
seen by experiments showing that HWP1 defective C. albicans
does not cause oropharyngeal candidiasis in mice.22 Interestingly,
recent in vivo experiments using an hwp1D/D mutant have sug-
gested that the role of Hwp1p in epithelial interaction/adhesion
may be niche-specific, playing a role in virulence at mucosal sur-
faces, impacting on whether the fungus becomes disseminated to
cause systemic infections, but playing no direct role in blood-
stream, systemic infections.23
Perhaps the most well-known C. albicans adhesins are the ALS
(Agglutinin-Like Sequence) family expressed on yeast and/or
hyphae. The eight members of this gene family (ALS1–7 and
ALS9) encode for large glycoproteins that are GPI-linked to the
b-1,6-glucans of the fungal cell wall and share a similar 3 domain
structure,24-26 with adherence being a property of the N-terminal
domain.26,27 These N-terminal domains have been predicted to
share structural similarities with bacterial adhesins.26 By studying
the ability of deletion mutants to adhere, Als2p, Als3p and Als4p
have been implicated as the primary human epithelial Als adhe-
sins,28,29 with contradictory evidence supporting or denying a
role for Als1p.28,30 Likewise, evidence for other members of the
ALS family (Als5p, Als6p and Als7p) is somewhat contradictory,
with both deletion mutants and S. cerevisiae over-expression
mutants showing increased adherence.26,31
As well as Hwp1p and Als family proteins, other adhesins have
been identified. Among these, Eap1p (Enhanced Adhesions to
Polystyrene) was identified based on similarity to a Saccharomyces
cerevisiae GPI-linked protein that mediates adherence to polysty-
rene beads32,33 and has now been shown to also mediate adhesion
to epithelial cells. One of the more recently discovered adhesins is
Iff4p. Overexpression of this cell surface protein increases adher-
ence to oral epithelial cells,34 while an iff4D/D null mutant shows
reduced binding to plastic.35
Recognition and Activation
Once the C. albicans cells have adhered to the epithelial cell
surface, 2 key events then take place–recognition and invasion.
The recognition process needs to function in a way to discrimi-
nate between commensal and pathogenic phases of C. albicans
growth/colonisation. Given the number of microbes resident at
epithelial surfaces, the cells that comprise these surfaces (predom-
inantly epithelial cells) must have evolved mechanisms to be able
to identify and respond only to those microbes which will cause
disease and damage, while remaining non-responsive to those
which are commensal. In recent years, the role that epithelial cells
play in this process has become increasingly apparent–particu-
larly in the case of C. albicans. It is well established that epithelial
cells produce a variety of cytokines in response to the presence of
this fungus, including G-CSF, GM-CSF, IL-1a, IL-1b and IL-
6, along with the chemokines RANTES, IL-8 and MIP3a.36-40
In addition to cytokines, epithelial cells have also been shown to
produce a variety of antimicrobial peptides in response to the
Table 1. Different C. albicans adhesins that mediate binding to epithelial
surfaces and their target host molecules
Candida adhesin Cellular receptor/substrate Reference
Eap1p Polystyrene, epithelial cells 32,33
Iff4p Plastic, epithelial cells 34,35
Hwp1p Host cell transglutaminsae substrates 20,21
Int1p iC3b 83
Als3p E-Cadherin, EGFR/Her2 19,52
GlcNAc-binding protein N-Acetylglucosamine 42,79
Fimbrial adhesin bGalNAc(1–4b-Gal) 78
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presence of C. albicans, including b-defensins and cathelicidin
(LL-37).41 These anti-microbial proteins kill C. albicans using a
variety of mechanisms involving interactions with the cell wall.
For example, LL-37 induces cell wall reorganisation and thin-
ning, as well as affecting the fungal transcriptome.42 The impor-
tance of these antimicrobial peptides in host mucosal responses
to this fungus is underlined by the role that the S100A8 alarmin
plays in host responses in vulvovaginal candidiasis.43,44 What has
not been apparent until recently is whether these secreted prod-
ucts are the result of a response to cellular damage or a specific
response to the fungus. Now, however, it has become apparent
that epithelial cells have developed a mechanism that enables
them to discriminate between the colonising yeast and the inva-
sive hyphal form of this fungus37 (Fig. 2), with an early, transient
response to yeast followed by a later, stronger response to hyphae,
which in turn leads to activation of epithelial cells and the pro-
duction of cytokines and other inflammatory mediators. This
work has identified that epithelial cells rapidly respond to the
presence of any form of the fungus, activating 5 key intracellular
signaling pathways–the 3 main Mitogen Activated Protein Kinase
(MAPK) pathways (JNK, p38 and ERK1/2), the Phosphatidyli-
nositide-3-kinase (PI3K) pathway and the Nuclear Factor-kappa-
enhancer of B cell function (NF-kB) pathway.36,37,45,46 Strik-
ingly, although the b-glucan receptor, dectin-1, has been
reported as a major receptor in myeloid cell recognition of Can-
dida species, there is no evidence to indicate activation of this
receptor in epithelial cells when they interact with C. albicans.
Tyrosine phosphorylation of Spleen Tyrosine Kinase (SYK) (an
event synonymous with dectin-1 activation) is not induced when
epithelial cells are infected with C. albicans, nor does stimulation
of epithelial cells with b-glucan activate MAPK/MKP1/c-Fos sig-
nalling.37 This is despite dectin-1 gene expression being detected
in oral gingival epithelial cells, albeit at low levels.47 What is con-
spicuous about the activation of these pathways is that although
NF-kB and PI3K signaling show consistent up regulation during
the first 3 hours of interaction, the MAPK pathways and their
subsequent downstream transcription factors show a more
dynamic activation profile.36,37,46 In contrast to the other 2 path-
ways, MAPK signaling has 2 phases. An initial, transient, mor-
phology-independent activation of all 3 pathways leading to JNK
and ERK1/2 dependent activation of the c-Jun transcription fac-
tor. This is an early response that appears by 5 minutes post-
infection, but rapidly fades, having disappeared by 1 hour. This
initial response is followed by a sustained reactivation of all 3
MAPK pathways at 2 hours, but now leading to activation of the
c-Fos transcription factor (driven by p38) and phosphorylation
of the MAPK phosphatase, MKP1 (driven by ERK1/2). Along
with cell culture, these factors are found in human biopsies, sug-
gesting that they are activated in vivo as well as in vitro. This sec-
ond phase is dependent on the presence of hyphae, with only
hypha producing strains of Candida capable of inducing this
response.37,45 It is not simply the presence of hyphae that affect
Figure 1. Adhesion and endocytosis of Candida albicans hyphae by epithelial cells. C. albicans induces its endocytic uptake by oral epithelial cells in 2
stages. In the ﬁrst stage, adhesins such as Als3p bind to their target cellular receptors (e.g., Als3p-E-cadherin) or bind covalently to the cell surface after
processing by host cell enzymes (e.g., Hwp1p and host transglutaminases). These actions ensure that the hyphal cells are securely bound to the epithelial
cell surface. In the second stage, the C. albicans invasins Als3p and Ssa1p interact with target host receptors, E-cadherin and the EGFR/Her2 heterodimer,
triggering activation of these receptors. This, in turn, leads to the induction of endocytosis via recruitment of clathrin and cytoskeletal reorganisation to
form an invasion pocket down which the hypha invades into the host cell.
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epithelial activation, but the levels of hyphal burden.37 Below a
certain threshold level, even the presence of hyphae goes unde-
tected. Importantly, different tissues (oral and vaginal) show dif-
fering sensitivities.36,37 The results of these differing sensitivities
can be seen in human live challenge experiments of vulvovaginal
candidiasis (VVC).48 In these experiments, women with no or lit-
tle previous history of VVC who developed recurrent episodes of
VVC post-challenge were found to show a higher sensitivity to
Candida fungal burdens than women with one or less occur-
rences of post-challenge VVC. The second epithelial signaling
response (c-Fos), but not the first (c-Jun) is essential for the pro-
duction of the majority of cytokines secreted by epithelial cells in
response to C. albicans,37 indicating that it is part of the activa-
tory response to C. albicans. Studies indicate that this response is
common to multiple epithe-
lial sub-sets, having been
found in both oral and vagi-
nal epithelial cells.36,37 Fur-
ther, in vivo experiments
using hyphal or yeast
mutants demonstrated a
clear requirement for the
hyphal form to trigger dam-
age, pro-inflammatory cyto-
kine release and neutrophil
recruitment in a murine
model of vaginitis.49 How-
ever, the net effects of the
discriminatory pathway dif-
fer between epithelial cell
types, with differences in
the profile of cytokines/che-
mokines secreted.36,39,40
This may be explained by
differences in the initial rec-
ognition characteristics,
leading to altered activation
of c-Jun and ELK-1 tran-
scription factors.
Invasion
Induced endocytosis
Adhesion and recogni-
tion of C. albicans by epi-
thelial cells has a wide range
of effects through ligand-
receptor interactions. One
of the earliest effects of these
interactions is to trigger
host receptor signaling lead-
ing to cytoskeletal reorgan-
isation, forming membrane
processes that endocytose
surface adherent hyphae in
a clathrin-mediated mechanism.19,50-53 Notably, this reorganisa-
tion is not triggered by interactions with yeast cells. This ability
to induce host endocytosis mechanisms is a common feature of
many microbe-epithelial interactions, with many bacteria includ-
ing Salmonella, Shigella and Yersinia species utilizing similar
mechanisms.54,55 The key features of this induced endocytosis
mechanism is that it is host-driven, requiring the host cell to take
the active part in the process. In contrast, viability of the Candida
cell is not important in the process.51 Importantly, the ability to
induce this endocytic uptake is a function of location. Although
there is significant evidence to demonstrate endocytic uptake of
C. albicans by oral epithelial cells, uptake in the gut appears to be
independent of these endocytic mechanisms as it has not, so far,
been observed.56 The induction of endocytosis is a rapid event,
Figure 2. Epithelial cell recognition and discrimination of Candida albicans yeast and hyphae. Infection of Oral epi-
thelial cells by C. albicans results in the triggering of 3 dominant pathways, each with distinct functions. There are 2
phases of signal pathway activation by C. albicans. In phase 1, C. albicans cells are recognized in a morphologically
independent fashion, leading to activation of NF-kB, and mTOR via the PI3K/Akt pathway, involving activation of
PDK1 and Akt. Activation of PI3K/Akt/mTor signaling leads to initiation of the cellular damage protection responses,
as well as activation of an unknown transcription factor involved in growth factor transcription. There is also a low
level triggering of all 3 MAPK pathways (p38, JNK and ERK1/2) leading to activation of the c-Jun transcription factor.
Both JNK and ERK1/2 but not p38 play a role in this process. The role that p38 plays in this early phase is not yet
known. While NF-kB and PI3K/Akt/mTOR pathways showed sustained activation, triggering of MAPK signaling in
this phase is transient, and returns to resting levels after 1 hour if no further signal is received. When a burden
threshold of C. albicans hyphal cells is reached, a second phase is triggered. Through an as yet unidentiﬁed recep-
tor-ligand interaction, epithelial cells show further, stronger triggering of all 3 MAPK pathways, leading to induction
of c-Fos expression and DNA binding through the p38 pathway and stabilization of the MAPK phosphatase, MKP1
via ERK1/2-mediated phosphorylation. In conjunction with NF-kB and an mTOR induced transcription factor, c-Fos
then up-regulates the production of cytokines, chemokines and other inﬂammatory mediators. In parallel, MKP1
acts in a negative feedback loop to limit the activity of MAPK signaling by deactivating p38 and JNK.
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occurring within the first 4 hours after initial contact57 and
involves actin and other proteins associated with clathrin-medi-
ated endocytosis (CME).50 Another potential mechanism,
involving the small GTPases Cdc42, Rac1 and RhoA, and ZO-1
(Zonula Occludens) has also been identified,58 although at this
time, it is unclear whether this mechanism is involved in endocy-
tosis of fungal cells or shed/secreted fungal molecules.
A recent series of studies has begun to elucidate a model by
which C. albicans induces its endocytosis by epithelial cells,
involving receptor tyrosine kinases (RTKs) and E-cadherin
(Fig. 1). The adhesin/invasins Als3p and Ssa1p bind to and inter-
act with E-cadherin52,59 and the RTKs, EGFR and Her219 on
epithelial cell surfaces, inducing phosphorylation of EGFR and
Her2 by as yet unidentified mechanisms, leading to endocytic
uptake of the C. albicans cell through CME.50 Interestingly,
although EGFR and Her2 appear to operate as a heterodimer to
induce these responses, they are also capable of functioning inde-
pendently of each other, as cells expressing only Her2 are still
able to endocytose C. albicans.19 Importantly, endocytosis can
also be induced by E-cadherin, as cells expressing this surface
receptor are still able to endocytose fungal cells in the absence of
EGFR/Her2 expression.19 Further, Her2 and E-cadherin func-
tion as part of the same pathway, as inhibiting both leads to no
further decrease in endocytosis than inhibiting each individu-
ally.19 This induction of endocytosis through RTKs is far from
unique to C. albicans with both E-cadherin and the RTK, MET,
having been shown to be involved in endocytosis of Listeria
monocytogenes.60,61
As well as the Als3/Ssa1-E-cadherin/Her2 mechanism, other
Candida proteins have been proposed to play a role in the induc-
tion of endocytosis. A null mutant of the pH regulation tran-
scription factor Rim101p has been shown to have a reduced
ability to induce its own endocytosis by oral epithelial cells.62
However, a group of cell surface proteins regulated by this tran-
scription factor (the cell surface chitinase Cht2p, the cell surface
protein Pga7p and the plasma membrane zinc transporter Zrt1p)
have been identified that when overexpressed in the rim101D/D
mutant restore the ability of this mutant to induce endocytosis.62
What is unclear is whether the actions of these proteins are a
direct effect or whether they are acting through an indirect pro-
cess – e.g., by affecting cell wall properties and activities.
Active penetration
Most of the mucosal surfaces that support Candida colonisa-
tion (e.g., oral cavity, vaginal lumen) consist of stratified, squa-
mous epithelium. In these structures, the surface layers are
terminally differentiated and thus non-proliferative. Conven-
tional wisdom regards them as being functionally inactive and, as
a result, they are unlikely to be able to support active endocytic
processes to internalise fungal cells. Given this, C. albicans needs
an alternative method of cell entry referred to as active penetra-
tion. Distinct from endocytic mechanisms, this process requires
viable hyphae invading through or between individual epithelial
cells, whether dead or alive, even with endocytic mechanisms
blocked.53,56 The exact processes and proteins involved in active
penetration are currently poorly understood, despite being the
subject of many studies. It is known that the adhesins important
in endocytic uptake, such as Als3p do not play an essential role
in this active penetration.53 However, even if they play no active
role in the penetrative process, they are likely to have a peripheral
role via indirect mechanisms such as anchoring to epithelial cell
surfaces.
Besides hyphal formation and maintenance, the only other
factors that have so far been implicated as playing a role in this
process are the Secreted Aspartic Protease (SAP) family. Indeed,
experiments using the protease inhibitor, pepstatin A, indicate
that in the presence of this inhibitor, C. albicans shows a reduced
ability to damage oral epithelium.63 However, this association is
debatable, as other studies, using sap deletion mutants, have not
shown the same effect.64 It is probable that the main contribution
of these enzymes is not in the active penetration of the epithelial
cells themselves, but rather in penetrating between individual
cells and epithelial layers. For example, Sap5p released by C. albi-
cans hyphae degrades the epithelial tight junction protein, E-cad-
herin.65 Degradation of this host protein is, therefore, likely to
lead to disruption of the epithelium and allow greater ease of
hyphal penetration into the mucosal tissues. Notably, despite a
plethora of other secreted enzymes such as lipases and phospholi-
pases as well as other proteases, none have been implicated as
playing a role in active penetration of epithelial cells.56
Damage
The processes of active penetration and induced endocytosis
of viable, wild-type C. albicans both carry the end result of dam-
age to the epithelial cell via a combination of 2 distinct mecha-
nisms: necrosis and apoptosis. Most recently, a new damage
mechanism called pyroptosis has been identified in the damage
of macrophages by C. albicans, but it is currently unknown if this
inflammasome-driven mechanism is also a factor in epithelial cell
damage.66,67 Damage of epithelial cells and loss of epithelium is
a key feature of mucosal candidiasis,68 and this is reflected in cell
culture, where infection results in significant levels of dam-
age.36,37,45,46 An in vivo study exploring damage caused by
hyphal versus non-hyphal mutants demonstrated the latter
induced significantly lower cell damage. However, some mutants
that form hyphae still showed reduced damage, suggesting that
specific hyphal effectors and not just hyphae are important for
causing damage in vivo.49 Although it seems obvious that active
penetration will cause damage, given the mechanism, process and
outcomes, it is less obvious that endocytosis would cause damage.
However, studies blocking the induction of Candida endocyto-
sis51 or using mutants with defects in inducing epithelial endocy-
tosis51,52,62,69 indicate that in these circumstances, damage is
reduced. It is, however, important to note here that the endocyto-
sis of Candida cells is not, in itself, enough to cause damage, as
the endocytosed Candida cells need to be both viable and have
normal damage-inducing genes to damage epithelial cells after
endocytosis.37,56,62 Thus, invasion alone is not enough to cause
damage – a finding strongly supported by data obtained using
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the adherence and invasion competent but damage incompetent
eed1D/D null mutant.37,70
It is most likely that the induction of damage during induced
endocytosis is via active penetration of the endocytic compart-
ment into which the Candida cell has been taken up. Thus, dam-
age of epithelial cells by active penetration may occur both
directly at the epithelial cell surface, or from with the endocytic
compartment subsequent to induced endocytosis of a fungal cell.
This picture is further complicated by the finding that epithe-
lial cells have a damage protection/prevention strategy that acti-
vates in response to the presence of C. albicans cells.46 This
mechanism is morphologically independent, and is dependent
on a PI3K/Akt/mTOR epithelial cell signaling circuit. While
activation of this circuit does not block Candida-induced dam-
age, suppression results in infection driving greater levels of
damage.46
A multitude of fungal factors have been implicated in damag-
ing epithelial cells, with some, such as the SAPs having arguments
both for and against (see above). Attempts with large panels of
fungal deletion mutants, have been made to screen for potential
fungal factors involved in the epithelial cell damage process, as
well as those involved in either adhesion or invasion.53 The
results of this study revealed a panel of genes involved in all 3 of
these functions (RIM101, HGC1, TUP1, TEC1, TPK1, RAS1,
EFG1, VPS1, ALS3, ECM33). Curiously, with the exception of
ALS3, all these genes play a role in the yeast-hyphal morphologi-
cal switch. This clearly demonstrates the importance of this
switch in these infection processes. This study further identified
2 genes involved in glycerol biosynthesis (GPD2 and GPP1) and
a further gene involved in hyphal extension (EED1) that exhib-
ited normal adhesion and invasion, but reduced damage, impli-
cating a role for these processes in causing necrotic damage of
epithelial cells.
Apoptosis
Programmed cell death, or apoptosis, is an important host
response in many diseases, and involves a series of events, usually
triggered by a family of cysteine aspartic proteases called cas-
pases.71,72 In the last few years, it has been shown that Candida
can induce apoptosis in epithelial cells,57,73 as well as being able
to inactivate the anti-apoptotic proteins Bcl-2 and Bcl-xL in mac-
rophages and neutrophils.74,75 Similar studies investigating bac-
terial infection of epithelial cells have indicated that apoptosis is a
delayed response, occurring late in the infection time line, rather
than part of the initial response to microbial recognition.76 How-
ever, microarray data of cells infected with C. albicans indicate
that both pro- and anti-apoptotic genes are activated even as early
as 6 hours post-infection.46 Along with data from another study
indicating that apoptosis is an early event and is followed by
necrosis,57 these data suggest that, unlike bacterial infection, apo-
ptosis is an early event during C. albicans infections. In this study,
the authors report that the dynamics of cell death during C. albi-
cans infection of epithelial cells involves early induction of apo-
ptosis, followed later by necrotic death. Apoptotic events in this
study were defined by increased numbers of cells showing
Annexin V on their surface, along with internucleosomal degra-
dation of nuclear chromatin. In confirmation of these findings,
treatment of epithelial cells with a pan-caspase inhibitor
(Z-VAD-FMK) that blocks caspase-mediated apoptosis and cell
death resulted in significant reductions in the level of cell death
during the first 12 hours of infection, although after this time,
levels of cell death were normal, demonstrating the later role that
necrosis plays in late epithelial cell death. Notably, inhibiting
endocytosis of the fungus has been shown to result in a decrease
in early apoptotic events,57 highlighting the potentially impor-
tant role that this process may play in epithelial cell death. A sub-
sequent study has identified that although early apoptotic events
are induced in response to C. albicans in »50% of oral epithelial
cells, only 15% of these cells move into late apoptotic events,
indicating that there is a block in the apoptotic process in these
cells.73 In common with our microarray findings,46 the authors
of this study found a significant increase of some anti-apoptotic
genes with an accompanying decrease in other pro-apoptotic
genes. Thus it would appear that although C. albicans can initiate
apoptosis pathways, epithelial cell responses limit these pathways
to ensure that only a minority of cells progress. Given the protec-
tive effects mediated by PI3K/Akt/mTor signalling,46 it is possi-
ble that this pathway plays some role in this block.
The fungal components that induce cell death are not well
known and little data is available to identify them. Currently,
only 2 components have been proposed with evidence to support
their role. In common with other PAMP effects, -N- and O-
linked glycosylation of mannoproteins has been shown to be of
significant importance in apoptosis, inducing cell cycle arrest and
apoptosis in oral epithelial cells.77 Interestingly, there appears to
be a hierarchy of importance. Experiments using mutants in key
mannosylation enzymes (och1D/D (N-mannosylation), mnt1/
mnt2D/D (O-linked mannosylation) and pmr1D/D (N- and O-
linked mannosylation) have identified that the loss of O-linked
glycosylation alone appears to have little effect on C. albicans cell
wall induction of apoptosis, while loss of N-linked glycosylation
results in a large reduction. However, the combination of loss of
both -N- and O-linked glycosylation results in almost complete
inability to induce apoptosis. It is important to note, however,
that some of these mutants have been shown to be defective in
morphogenesis, demonstrating aberrant abilities to form
hyphae,78-80 and it is possible that this may provide partial expla-
nation for the loss in ability to induce apoptosis. The quorum
sensing molecule, farnesol, has also been proposed as a potential
activator of oral epithelial cell apoptosis.81 However, there are a
number of key issues with these findings as they relate to physio-
logical conditions. Firstly, given that farnesol is a secreted mole-
cule, it seems unlikely that it could induce apoptosis in a fungal-
contact-dependent manner. It is possible that high local concen-
trations of farnesol are required to trigger apoptosis, although
how achievable these levels would be, given the diluting and
washing effects of saliva in the locality, is unknown. It is possible
however, that sufficient concentrations of farnesol may be
achieved at a local level by collection/secretion in the contact-
dependent invasion pocket (Fig. 1B), rather than through
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achieving a high global concentration in the environment as a
whole. This may also hold true for other fungal factors affecting
epithelial cells.
Concluding Remarks
In this review we have explored how theories of the role of epi-
thelial cells in host-C. albicans interactions have changed from
that of a static barrier, to dynamically reactive sentinels that are
the first responders to invasive infections. With the advances in
our knowledge over the last decade we can now begin to build a
picture showing that interactions between epithelial cells and C.
albicans are key to host responses to this medically important
fungal pathogen. The series of events outlined in this review
describe a process whereby C. albicans adheres to epithelial cells,
triggers a series of signaling circuits that result in i.) recognition
of specific morphological types of the fungus and ii.) induction
of endocytosis. Endocytosed C. albicans then initiates early apo-
ptotic events followed by phagosomal escape through active pen-
etration, with these events resulting in damage to the epithelial
cell. These early recognition events result in the epithelial cell
mitigating some of the effects of this early damage – possibly by
causing the block in progression of apoptotic signaling that is
observed. It is key to our understanding of mucosal immunity to
this fungus to note that these events do not happen in isolation,
and that other cell types have a critical effect on epithelial
responses to C. albicans. Neutrophils, in particular, appear to
play an important role in epithelial anti-Candida defense, secret-
ing factors that induce epithelial cell protection against damage
in a TLR4-dependent manner.82 Notably, this protection is
dependent on epithelial activation of neutrophils. Thus, epithe-
lial cells are one key component of the host response circuit to
fungal infections. While the last 10 y has seen a dramatic increase
in our knowledge and understanding of the important role that
epithelial cells play in host responses, we have barely scratched
the surface of their function, and the next decade and beyond
will, without doubt, see our appreciation of the functionality of
epithelial cells in host-fungal interactions advance exponentially.
From the clinical standpoint, these advances promise the pros-
pects of entirely novel therapeutic strategies that will revolution-
ise the treatment of not just Candida and fungal infections, but
other, equally important mucosal infections.
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